Physician profile
Brandy M German
NPI 1457623928
$3,969.24
in general payments reported to CMS, 2019-2025
34 companies · $786 in 2025
The $786 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,122 · 2022: $651 · 2023: $423 · 2024: $987 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,195.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $883.73 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $504.55 | 2021-2025 | |
| Glaxosmithkline, LLC. | $339.01 | 2021-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $318.89 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $298.09 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.41 | 2021-2023 | Jardiance, Stiolto Respimat |
| Axsome Therapeutics, INC. | $193.94 | 2024-2025 | Auvelity |
| Ucb, INC. | $124.20 | 2024 | Nayzilam |
| Dexcom, INC. | $119.41 | 2021-2025 | Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $100.00 | 2021 | |
| Amarin Pharma, INC. | $99.99 | 2021-2022 | |
| Exact Sciences Corporation | $95.64 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $66.58 | 2021-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $63.91 | 2021-2024 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $56.98 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $53.58 | 2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $48.87 | 2021-2023 | Xarelto |
| Xeris Pharmaceuticals, INC. | $47.64 | 2022-2024 | Gvoke Hypopen |
| Biohaven Pharmaceuticals, INC. | $44.37 | 2021 | |
| Corium, LLC | $35.30 | 2023-2025 | Azstarys |
| Phathom Pharmaceuticals, INC. | $31.13 | 2024-2025 | Voquezna |
| Amgen INC. | $28.09 | 2025 | Repatha, Otezla, Evenity |
| Philips North America LLC | $20.23 | 2025 | Extended Holter |
| Bayer Healthcare Pharmaceuticals INC. | $18.98 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $18.29 | 2021 | |
| Pfizer INC. | $16.85 | 2023 | |
| Sanofi-Aventis U.S. LLC | $16.71 | 2021 | |
| Bausch Health US, LLC | $16.37 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.48 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.20 | 2022 | |
| Alexion Pharmaceuticals, INC. | $13.12 | 2024 | Koselugo |
| Organogenesis INC. | $12.92 | 2021 | |
| Merck Sharp & Dohme LLC | $12.05 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy German listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.